Skip to main content

Peer Review reports

From: AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer

Original Submission
20 Feb 2020 Submitted Original manuscript
6 Apr 2020 Reviewed Reviewer Report - Kiichi Sugimoto
9 May 2020 Reviewed Reviewer Report
17 May 2020 Reviewed Reviewer Report
24 May 2020 Reviewed Reviewer Report - Richard Wilson
19 Jun 2020 Author responded Author comments - Carlotta Antoniotti
Resubmission - Version 2
19 Jun 2020 Submitted Manuscript version 2
7 Jul 2020 Author responded Author comments - Carlotta Antoniotti
Resubmission - Version 3
7 Jul 2020 Submitted Manuscript version 3
9 Jul 2020 Author responded Author comments - Carlotta Antoniotti
Resubmission - Version 4
9 Jul 2020 Submitted Manuscript version 4
Publishing
12 Jul 2020 Editorially accepted
22 Jul 2020 Article published 10.1186/s12885-020-07169-6

You can find further information about peer review here.

Back to article page